Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Opexa Therapeutics Stories

2014-04-01 20:21:51

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7vkq8r/global_stem_cell) has announced the addition of the "Global Stem Cell Umbilical Cord Blood (UCB) Market - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast to 2020" [http://www.researchandmarkets.com/research/7vkq8r/global_stem_cell ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2014-02-03 16:24:49

DUBLIN, Ireland, February 3, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2c2thn/stem_cell_markets) has announced the addition of the "Concise Analysis of the International Stem Cell Markets" [http://www.researchandmarkets.com/research/2c2thn/stem_cell_markets ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) A stem cell is an extraordinary type of cell that has the ability to...

2014-02-03 12:27:00

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Stem Cell Markets A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology...

2013-11-07 16:28:01

DUBLIN, November 7, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/l9klxc/autologous_stem) has announced the addition of the "Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)" [http://www.researchandmarkets.com/research/l9klxc/autologous_stem ] report to their offering. (Logo:...

2013-11-05 23:04:29

Reportbuyer.com just published a new market research report: Stem Cell Markets. London (PRWEB) November 05, 2013 A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide...

2013-10-14 08:25:37

Scottish Development International and leading industry players, Sistemic and Roslin Cells, are committed to linking cell therapy clinical trials to the most up-to-date technologies to drive wider adoption of the ground-breaking field. GLASGOW, Scotland, Oct. 14, 2013 /PRNewswire/ -- Scotland announced today that leading industry players, Sistemic and Roslin Cells, are going to work together with Scottish Development International to make the process of undertaking clinical trials in...

2012-11-26 16:24:39

PHILADELPHIA, Nov. 26, 2012 /PRNewswire/ -- RRY Publications LLC today announced that the use of stem cell therapies in 2012 significantly exceeded forecasts which were originally presented at the February 2012 New York Stem Cell Summit. Said Robin Young, stem cell industry analyst and host of the New York meeting: "The range and scope of stem cell therapeutic use in the United States grew much faster than we'd forecasted earlier this year. Virtually all of the increases we're seeing are for...

2012-09-27 02:26:34

CARLSBAD, Calif., Sept. 27, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it has received FDA 510(k) clearance for its OpTmizer(TM) CTS(TM) T-Cell Expansion Tissue Culture Medium - a reagent that is now cleared as a Class II medical device and offers cost- and time-saving advantages for transitioning studies from the research bench to clinical trials. The OpTmizer(TM) CTS(TM) T-Cell Expansion Tissue Culture Medium is intended for human ex vivo (outside the...

2012-08-02 06:24:22

HOUSTON, Aug. 2, 2012 /PRNewswire/ -- Celltex Therapeutics Corporation, a leader in regenerative medicine services, today announced the appointments of Andrea Ferrenz, Executive Vice President, Legal Counsel, and Jane Shen Young, Manufacturing Research Scientist. Ferrenz's primary responsibility will be overseeing operations, including compliance with federal and state regulatory agencies. Young's primary responsibility will be research and development of manufacturing processes and products...

2011-11-25 16:01:00

NATICK, Mass., Nov. 25, 2011 /PRNewswire/ -- RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) , a leader in adult stem cell therapy, is pleased to announce that its wholly owned subsidiary Regenocell, Ltd. is in the final stages of negotiations with several potential new distributors. It is anticipated that one or more will be finalized by year end and begin purchasing cell processing services in the near term. This will have a beneficial impact on revenues generated by the cell...